Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3182)
All Articles published online
|
Nov 21, 2006 (publication date) through May 1, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tonus C, Neupert G, Sellinger M. Colorectal cancer screening by non-invasive metabolic biomarker fecal tumor M2-PK. World J Gastroenterol 2006; 12(43): 7007-7011 [PMID: 17109496 DOI: 10.3748/wjg.v12.i43.7007] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i43/7007.htm |
| Number | Citing Articles |
| 1 |
M V Kruchinina, A A Gromov, Y I Prudnikova, V M Generalov, V N Kruchinin, V A Volodin, G V Shuvalov, O V Minin, S V Shehovtsov, S E Peltec, I V Minin. Application of ellipsometry, spr-technic and raman-spectroscopy into diagnosis of colorectal cancer. IOP Conference Series: Materials Science and Engineering 2019; 516: 012017 doi: 10.1088/1757-899X/516/1/012017
|
| 2 |
Hamid Kalantari, Mahsa Khodadoostan, Majid Yaran, Abdolrasoul Tavakoli. Diagnostic value of pyruvate kinase isoenzyme type M2 in colon cancer proven with colonoscopy. Advanced Biomedical Research 2020; 9(1): 76 doi: 10.4103/abr.abr_91_20
|
| 3 |
Suresh Sithambaram, Ida Hilmi, Khean-Lee Goh, Lanjing Zhang. The Diagnostic Accuracy of the M2 Pyruvate Kinase Quick Stool Test- A Rapid Office Based Assay Test for the Detection of Colorectal Cancer. PLOS ONE 2015; 10(7): e0131616 doi: 10.1371/journal.pone.0131616
|
| 4 |
Sybille Mazurek. Pyruvate kinase type M2: A key regulator of the metabolic budget system in tumor cells. The International Journal of Biochemistry & Cell Biology 2011; 43(7): 969 doi: 10.1016/j.biocel.2010.02.005
|
| 5 |
Xiufeng Liu, Zhenhu Chen. Proceedings of the International Conference on Information Engineering and Applications (IEA) 2012. Lecture Notes in Electrical Engineering 2013; 216: 265 doi: 10.1007/978-1-4471-4856-2_33
|
| 6 |
Amir Hossein Aalami, Ali Shahriari, Mohammad Mazaheri, Farnoosh Aalami, Amir Amirabadi, Amirhossein Sahebkar. Diagnostic accuracy of tumor M2-pyruvate kinase (tM2-PK) as a non-invasive biomarker in colorectal cancer: A systematic review and meta-analysis. Clinical Biochemistry 2023; 120: 110652 doi: 10.1016/j.clinbiochem.2023.110652
|
| 7 |
Jürgen Stein, Stefan M. Loitsch, Yogesh Shastri. Non-invasive detection of colorectal cancer – do we still need the guaiac-based fecal occult blood test?1
. LaboratoriumsMedizin 2008; 32(3): - doi: 10.1515/JLM.2008.021et
|
| 8 |
Atefeh Nasir Kansestani, Mohammad Erfan Zare, Qingchao Tong, Jun Zhang. Comparison of faecal protein biomarkers' diagnostic accuracy for colorectal advanced neoplasms: a systematic review and meta-analysis. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-06689-4
|
| 9 |
Shilpa Joshi, Stephen J Lewis, Siobhan Creanor, Ruth M Ayling. Age-related faecal calprotectin, lactoferrin and tumour M2-PK concentrations in healthy volunteers. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 2010; 47(3): 259 doi: 10.1258/acb.2009.009061
|
| 10 |
Young S. Kim, Padma Maruvada. Frontiers in metabolomics for cancer research: Proceedings of a National Cancer Institute workshop. Metabolomics 2008; 4(2): 105 doi: 10.1007/s11306-008-0109-3
|
| 11 |
Zeinab Deris Zayeri, Abazar Parsi, Saeid Shahrabi, Masoud Kargar, Nader Davari, Najmaldin Saki. Epigenetic and metabolic reprogramming in inflammatory bowel diseases: diagnostic and prognostic biomarkers in colorectal cancer. Cancer Cell International 2023; 23(1) doi: 10.1186/s12935-023-03117-z
|
| 12 |
Sandra Tan, Cynthia R. M. Y. Liang, Khay Guan Yeoh, Jimmy So, Choy Leong Hew, Maxey C. M. Chung. Gastrointestinal fluids proteomics. PROTEOMICS – Clinical Applications 2007; 1(8): 820 doi: 10.1002/prca.200700169
|
| 13 |
Ruth M Ayling. New faecal tests in gastroenterology. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 2012; 49(1): 44 doi: 10.1258/acb.2011.011150
|
| 14 |
K. F. Newton, W. Newman, J. Hill. Review of biomarkers in colorectal cancer. Colorectal Disease 2012; 14(1): 3 doi: 10.1111/j.1463-1318.2010.02439.x
|
| 15 |
Yogesh M. Shastri, Stefan Loitsch, Nicolas Hoepffner, Nada Povse, Ernst Hanisch, Wolfgang Rösch, Joachim Mössner, Jürgen M. Stein. Comparison of an Established Simple Office-Based Immunological FOBT With Fecal Tumor Pyruvate Kinase Type M2 (M2-PK) for Colorectal Cancer Screening: Prospective Multicenter Study. The American Journal of Gastroenterology 2008; 103(6): 1496 doi: 10.1111/j.1572-0241.2008.01824.x
|
| 16 |
Philip D Hardt, Nils Ewald. Tumor M2 pyruvate kinase: a tumor marker and its clinical application in gastrointestinal malignancy. Expert Review of Molecular Diagnostics 2008; 8(5): 579 doi: 10.1586/14737159.8.5.579
|
| 17 |
A. Loganayagam. Faecal screening of colorectal cancer. International Journal of Clinical Practice 2007; 62(3): 454 doi: 10.1111/j.1742-1241.2007.01532.x
|
| 18 |
Sarah Strohkamp, Timo Gemoll, Sina Humborg, Sonja Hartwig, Stefan Lehr, Sandra Freitag-Wolf, Susanne Becker, Bo Franzén, Ralph Pries, Barbara Wollenberg, Uwe J. Roblick, Hans-Peter Bruch, Tobias Keck, Gert Auer, Jens K. Habermann. Protein levels of clusterin and glutathione synthetase in platelets allow for early detection of colorectal cancer. Cellular and Molecular Life Sciences 2018; 75(2): 323 doi: 10.1007/s00018-017-2631-9
|
| 19 |
Jasmina Saric, Yulan Wang, Jia Li, Muireann Coen, Jürg Utzinger, Julian R. Marchesi, Jennifer Keiser, Kirill Veselkov, John C. Lindon, Jeremy K. Nicholson, Elaine Holmes. Species Variation in the Fecal Metabolome Gives Insight into Differential Gastrointestinal Function. Journal of Proteome Research 2008; 7(1): 352 doi: 10.1021/pr070340k
|
| 20 |
Wen Meng, Hong-Hong Zhu, Ze-Feng Xu, Shan-Rong Cai, Qi Dong, Qiang-Rong Pan, Shu Zheng, Su-Zhan Zhang. Serum M2-pyruvate kinase: A promising non-invasive biomarker for colorectal cancer mass screening. World Journal of Gastrointestinal Oncology 2012; 4(6): 145-151 doi: 10.4251/wjgo.v4.i6.145
|
| 21 |
Ashley Bond, Rosemary Greenwood, Stephen Lewis, Bernard Corfe, Sanchoy Sarkar, Paul O'Toole, Paul Rooney, Michael Burkitt, Georgina Hold, Chris Probert. Volatile organic compounds emitted from faeces as a biomarker for colorectal cancer. Alimentary Pharmacology & Therapeutics 2019; 49(8): 1005 doi: 10.1111/apt.15140
|
| 22 |
Harsha R. Hathurusinghe, Kolitha S. Goonetilleke, Ajith K. Siriwardena. Current Status of Tumor M2 Pyruvate Kinase (Tumor M2-PK) as a Biomarker of Gastrointestinal Malignancy. Annals of Surgical Oncology 2007; 14(10): 2714 doi: 10.1245/s10434-007-9481-x
|
| 23 |
Jinny Jeffery, Stephen J. Lewis, Ruth M. Ayling. Fecal dimeric M2-pyruvate kinase (tumor M2-PK) in the differential diagnosis of functional and organic bowel disorders. Inflammatory Bowel Diseases 2009; 15(11): 1630 doi: 10.1002/ibd.20946
|
| 24 |
|
| 25 |
Judith YMN Derijks-Engwegen, Annemieke Cats, Marianne E Smits, Jan HM Schellens, Jos H Beijnen. Improving colorectal cancer management: the potential of proteomics. Biomarkers in Medicine 2008; 2(3): 253 doi: 10.2217/17520363.2.3.253
|
| 26 |
Ching-Seng Ang, Julie Rothacker, Heather Patsiouras, Antony W. Burgess, Edouard C. Nice. Murine fecal proteomics: A model system for the detection of potential biomarkers for colorectal cancer. Journal of Chromatography A 2010; 1217(19): 3330 doi: 10.1016/j.chroma.2009.10.007
|
| 27 |
Aslı Hapa, Gül Erkin, Gülşen Hasçelik, Dilara Pektaş, Umut Arslan. Plasma TM2-PK levels in mycosis fungoides patients. Archives of Dermatological Research 2011; 303(1): 35 doi: 10.1007/s00403-010-1085-9
|
| 28 |
Ching‐Seng Ang, Jason Phung, Edouard C. Nice. The discovery and validation of colorectal cancer biomarkers. Biomedical Chromatography 2011; 25(1-2): 82 doi: 10.1002/bmc.1528
|
| 29 |
Banafsheh Zeinali-Rafsanjani, Reza jalli, Mahdi Saeedi-Moghadam, Parisa Pishdad. Magnetic resonance spectroscopy and its application in colorectal cancer diagnosis and screening: A narrative review. Journal of Medical Imaging and Radiation Sciences 2020; 51(4): 654 doi: 10.1016/j.jmir.2020.07.004
|
| 30 |
Melissa Oliveira-Cunha, Ajith K. Siriwardena, Richard Byers. Molecular diagnosis in pancreatic cancer. Diagnostic Histopathology 2008; 14(5): 214 doi: 10.1016/j.mpdhp.2008.03.004
|
| 31 |
Rui Li, Jianjun Liu, Huiping Xue, Gang Huang. Diagnostic value of fecal tumor M2‐pyruvate kinase for CRC screening: A systematic review and meta‐analysis. International Journal of Cancer 2012; 131(8): 1837 doi: 10.1002/ijc.27442
|
| 32 |
Fabrizio Parente, Barbara Marino, Antonina Ilardo, Pierluigi Fracasso, Angelo Zullo, Casare Hassan, Roberto Moretti, Marco Cremaschini, Antonio Ardizzoia, Ilaria Saracino, Federico Perna, Dino Vaira. A combination of faecal tests for the detection of colon cancer. European Journal of Gastroenterology & Hepatology 2012; 24(10): 1145 doi: 10.1097/MEG.0b013e328355cc79
|
| 33 |
Reena Shah, Emma Jones, Victoire Vidart, Peter J.K. Kuppen, John A. Conti, Nader K. Francis. Biomarkers for Early Detection of Colorectal Cancer and Polyps: Systematic Review. Cancer Epidemiology, Biomarkers & Prevention 2014; 23(9): 1712 doi: 10.1158/1055-9965.EPI-14-0412
|
| 34 |
Ozgecan Kayalar, Hadi Rajabi, Deniz Mortazavi, Hasan Bayram. Oncology: Genomics, Precision Medicine and Therapeutic Targets. 2023; : 237 doi: 10.1007/978-981-99-1529-3_9
|
| 35 |
|
| 36 |
Nasimeh Vatandoost, Jahanafrooz Ghanbari, Mahboobeh Mojaver, Amir Avan, Majid Ghayour-Mobarhan, Reza Nedaeinia, Rasoul Salehi. Early detection of colorectal cancer: from conventional methods to novel biomarkers. Journal of Cancer Research and Clinical Oncology 2016; 142(2): 341 doi: 10.1007/s00432-015-1928-z
|
| 37 |
Jill Tinmouth, Emily T. Vella, Nancy N. Baxter, Catherine Dubé, Michael Gould, Amanda Hey, Nofisat Ismaila, Bronwen R. McCurdy, Lawrence Paszat. Colorectal Cancer Screening in Average Risk Populations: Evidence Summary. Canadian Journal of Gastroenterology and Hepatology 2016; 2016: 1 doi: 10.1155/2016/2878149
|
| 38 |
U Haug, S Hundt, H Brenner. Sensitivity and specificity of faecal tumour M2 pyruvate kinase for detection of colorectal adenomas in a large screening study. British Journal of Cancer 2008; 99(1): 133 doi: 10.1038/sj.bjc.6604427
|
| 39 |
Yong Cheol Kim, Jeong Ho Kim, Dae Young Cheung, Tae Ho Kim, Eun Jung Jun, Jung-Whan Oh, Chang Whan Kim, Woo Chul Chung, Byung-Wook Kim, Sung Soo Kim, Jin Il Kim, Soo-Heon Park, Jae Kwang Kim. The Usefulness of a Novel Screening Kit for Colorectal Cancer Using the Immunochromatographic Fecal Tumor M2 Pyruvate Kinase Test. Gut and Liver 2015; 9(5) doi: 10.5009/gnl13457
|
| 40 |
Mallikarjuna Uppara, Franklin Adaba, Alan Askari, Susan Clark, George Hanna, Thanos Athanasiou, Omar Faiz. A systematic review and meta-analysis of the diagnostic accuracy of pyruvate kinase M2 isoenzymatic assay in diagnosing colorectal cancer. World Journal of Surgical Oncology 2015; 13(1): 48 doi: 10.1186/s12957-015-0446-4
|
| 41 |
Yoshikatsu Koga, Nobuyoshi Yamazaki, Yasuhiro Matsumura. New molecular diagnosis and screening methods for colorectal cancer using fecal protein, DNA and RNA. Expert Review of Molecular Diagnostics 2014; 14(1): 107 doi: 10.1586/14737159.2014.863152
|
| 42 |
Jürgen Stein, Stefan M. Loitsch, Yogesh Shastri. Nicht-invasive Diagnostik kolorektaler Tumore – Hat der Guaiac-Test ausgedient? / Non-invasive detection of colorectal cancer – do we still need the guaiac-based fecal occult blood test?. LaboratoriumsMedizin 2008; 32(3): 158 doi: 10.1515/JLM.2008.021
|
| 43 |
|